Neuropeutics

Neuropeutics is a pharmaceutical company developing targeted therapies to extend neurodegenerative disease patients’ survival and improve their quality of life. We have developed a first-in-class patent-pending small molecule with great efficacy in preclinical models of TDP-43 pathology.